 | 2H0 | 表記: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | 組成式: | C20 H34 N3 O5 P | SMILES: | O=C(NCCC(C)C)C(NP(=O)(O)CNC(=O)OCc1ccccc1)CC(C)C | InChi: | InChI=1S/C20H34N3O5P/c1-15(2)10-11-21-19(24)18(12-16(3)4)23-29(26,27)14-22-20(25)28-13-17-8-6-5-7-9-17/h5-9,15-16,18H,10-14H2,1-4H3,(H,21,24)(H,22,25)(H2,23,26,27)/t18-/m0/s1 | 別名: | N~2~-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(3-methylbutyl)-L-leucinamide | 定義日: | 2013-10-17 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-02 | 識別子(ID): | N~2~-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(3-methylbutyl)-L-leucinamide |
|
 | 2IW | 表記: | 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(4-methylquinolin-8-yl)benzamide | 組成式: | C26 H21 N3 O3 | SMILES: | O=C(Nc2c1nccc(c1ccc2)C)c3ccc(cc3)N5C(=O)C6C4C=CC(C4)C6C5=O | InChi: | InChI=1S/C26H21N3O3/c1-14-11-12-27-23-19(14)3-2-4-20(23)28-24(30)15-7-9-18(10-8-15)29-25(31)21-16-5-6-17(13-16)22(21)26(29)32/h2-12,16-17,21-22H,13H2,1H3,(H,28,30)/t16-,17+,21-,22+ | 別名: | IWR-2 | 定義日: | 2012-03-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(4-methylquinolin-8-yl)benzamide |
|
 | VN3 | 表記: | VANADATE ION | 組成式: | O3 V | SMILES: | O=[V-](=O)=O | InChi: | InChI=1S/3O.V/q | 別名: | METAVANADATE | 定義日: | 2005-07-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | trioxovanadate(1-) |
|
 | TNV | 表記: | [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYL-TRIPHOSPHATE | 組成式: | C9 H16 N5 O10 P3 | SMILES: | C[CH](Cn1cnc2c(N)ncnc12)OC[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O | InChi: | InChI=1S/C9H16N5O10P3/c1-6(2-14-4-13-7-8(10)11-3-12-9(7)14)22-5-25(15,16)23-27(20,21)24-26(17,18)19/h3-4,6H,2,5H2,1H3,(H,15,16)(H,20,21)(H2,10,11,12)(H2,17,18,19)/t6-/m1/s1 | 別名: | TENOFOVIR-DIPHOSPHATE | 定義日: | 2004-04-21 | 最終更新日: | 2021-03-01 | 識別子(ID): | [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(hydroxy-phosphonooxy-phosphoryl)oxy-phosphinic acid |
|
 | TOF | 表記: | 1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione | 組成式: | C7 H7 N5 O2 | SMILES: | O=C2N=C1C(=NC=NN1C)C(=O)N2C | InChi: | InChI=1S/C7H7N5O2/c1-11-6(13)4-5(10-7(11)14)12(2)9-3-8-4/h3H,1-2H3 | 別名: | Toxoflavin | 定義日: | 2010-09-27 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
|
 | TOR | 表記: | [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate | 組成式: | C12 H21 N O8 S | SMILES: | O=S(=O)(OCC23OCC1OC(OC1C3OC(O2)(C)C)(C)C)N | InChi: | InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1 | 別名: | topiramate | 定義日: | 2009-06-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate (non-preferred name) |
|
 | TP7 | 表記: | Coenzyme B | 組成式: | C11 H22 N O7 P S | SMILES: | C[CH](O[P](O)(O)=O)[CH](NC(=O)CCCCCCS)C(O)=O | InChi: | InChI=1S/C11H22NO7PS/c1-8(19-20(16,17)18)10(11(14)15)12-9(13)6-4-2-3-5-7-21/h8,10,21H,2-7H2,1H3,(H,12,13)(H,14,15)(H2,16,17,18)/t8-,10+/m1/s1 | 別名: | 7-MERCAPTOHEPTANOYLTHREONINEPHOSPHATE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3R)-3-phosphonooxy-2-(7-sulfanylheptanoylamino)butanoic acid |
|
 | 2L3 | 表記: | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | 組成式: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m1/s1 | 別名: | menadione bisulfite | 定義日: | 2013-11-25 | 最終更新日: | 2021-03-01 | 公開日: | 2014-02-19 | 識別子(ID): | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
 | 2LB | 表記: | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | 組成式: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m0/s1 | 別名: | menadione bisulfite | 定義日: | 2013-11-26 | 最終更新日: | 2021-03-01 | 公開日: | 2014-02-19 | 識別子(ID): | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
 | TPV | 表記: | N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE | 組成式: | C31 H33 F3 N2 O5 S | SMILES: | FC(F)(F)c1ccc(nc1)S(=O)(=O)Nc2cccc(c2)C(C=3C(=O)OC(CCC)(CC=3O)CCc4ccccc4)CC | InChi: | InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 | 別名: | TIPRANAVIR | 定義日: | 1999-10-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide |
|
 | 2NC | 表記: | N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide | 組成式: | C35 H68 N11 O8 | SMILES: | O=C(NC(C(=O)NC(CCCC)CNC(C(=O)NC(C(=O)NC(C(=O)N)CCCNC(=[NH2+])N)CCC(=O)N)CCCC)C(C)CC)C(NC(=O)C)C(O)C | InChi: | InChI=1S/C35H67N11O8/c1-7-10-13-23(43-33(53)28(20(4)9-3)46-34(54)29(21(5)47)42-22(6)48)19-41-25(14-11-8-2)31(51)45-26(16-17-27(36)49)32(52)44-24(30(37)50)15-12-18-40-35(38)39/h20-21,23-26,28-29,41,47H,7-19H2,1-6H3,(H2,36,49)(H2,37,50)(H,42,48)(H,43,53)(H,44,52)(H,45,51)(H,46,54)(H4,38,39,40)/p+1/t20-,21+,23-,24-,25-,26-,28-,29-/m0/s1 | 別名: | p2/NC | 定義日: | 2008-03-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide |
|
 | 2NV | 表記: | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 組成式: | C13 H29 N O5 | SMILES: | NC(C)COCCOCCOCCOCCOCC | InChi: | InChI=1S/C13H29NO5/c1-3-15-4-5-16-6-7-17-8-9-18-10-11-19-12-13(2)14/h13H,3-12,14H2,1-2H3/t13-/m1/s1 | 別名: | Jeffamine ED-2001 | 定義日: | 2014-04-21 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-30 | 識別子(ID): | (17R)-3,6,9,12,15-pentaoxaoctadecan-17-amine |
|
 | TS2 | 表記: | 2-AMINO-4-[4-(4-AMINO-4-CARBOXY-BUTYRYLAMINO)-5,8,19,22-TETRAOXO-1,2-DITHIA-6,9,13,18,21-PENTAAZA-CYCLOTETRACOS-23-YLCARBAMOYL]-BUTYRIC ACID | 組成式: | C27 H47 N9 O10 S2 | SMILES: | O=C(O)C(N)CCC(=O)NC1C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)C(NC(=O)CCC(C(=O)O)N)CSSC1 | InChi: | InChI=1S/C27H47N9O10S2/c28-16(26(43)44)4-6-20(37)35-18-14-47-48-15-19(36-21(38)7-5-17(29)27(45)46)25(42)34-13-23(40)32-11-3-9-30-8-1-2-10-31-22(39)12-33-24(18)41/h16-19,30H,1-15,28-29H2,(H,31,39)(H,32,40)(H,33,41)(H,34,42)(H,35,37)(H,36,38)(H,43,44)(H,45,46)/t16-,17-,18-,19-/m0/s1 | 別名: | RING WITH GLUTATHIONE AND SPERMIDINE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,2'S)-5,5'-{[(4R,23R)-5,8,19,22-tetraoxo-1,2-dithia-6,9,13,18,21-pentaazacyclotetracosane-4,23-diyl]diimino}bis(2-amino-5-oxopentanoic acid) (non-preferred name) |
|
 | B1R | 表記: | [(1,2,3,4,5-eta)-cyclopentadienyl][(1,2,3,4,5-eta)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}cyclopentadienyl]ruthenium | 組成式: | C20 H16 N2 O2 Ru S | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)C3%10C%12=C%11C6=C3[Ru]4564789%10C5=C4C9C8=C57 | InChi: | InChI=1S/C15H15N2O2S.C5H.Ru/c18-12(10-5-1-2-6-10)7-3-4-8-13-14-11(9-20-13)16-15(19)17-14 | 別名: | biotinylruthenocene | 定義日: | 2012-12-06 | 最終更新日: | 2021-03-01 | 公開日: | 2013-08-14 | 識別子(ID): | [(1,2,3,4,5-eta)-cyclopentadienyl][(1,2,3,4,5-eta)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}cyclopentadienyl]ruthenium |
|
 | TSX | 表記: | N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)-PHENYL]-ACETAMIDE | 組成式: | C21 H25 N5 O3 | SMILES: | O=C(Nc1ccc(cc1)Cc3nc2N(C(=O)N(C(=O)c2n3)CC=C)CCCC)C | InChi: | InChI=1S/C21H25N5O3/c1-4-6-12-25-19-18(20(28)26(11-5-2)21(25)29)23-17(24-19)13-15-7-9-16(10-8-15)22-14(3)27/h5,7-10H,2,4,6,11-13H2,1,3H3,(H,22,27)(H,23,24) | 別名: | 1-ALLYL-3-BUTYL-8-(N-ACETYL-4-AMINOBENZYL)-XANTHINE | 定義日: | 2002-07-09 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-{4-[(3-butyl-2,6-dioxo-1-prop-2-en-1-yl-2,3,6,7-tetrahydro-1H-purin-8-yl)methyl]phenyl}acetamide |
|
 | TTF | 表記: | 4,4,4-TRIFLUORO-1-THIEN-2-YLBUTANE-1,3-DIONE | 組成式: | C8 H5 F3 O2 S | SMILES: | O=C(c1sccc1)CC(=O)C(F)(F)F | InChi: | InChI=1S/C8H5F3O2S/c9-8(10,11)7(13)4-5(12)6-2-1-3-14-6/h1-3H,4H2 | 別名: | 2-THENOYLTRIFLUOROACETONE | 定義日: | 2005-05-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4,4,4-trifluoro-1-thiophen-2-ylbutane-1,3-dione |
|
 | TTG | 表記: | 2-(1-DIMETHYLAMINOMETHYL-2-HYDROXY-8-HYDROXYMETHYL-9-OXO-9,11-DIHYDRO-INDOLIZINO[1,2-B]QUINOLIN-7-YL)-2-HYDROXY-BUTYRIC ACID | 組成式: | C23 H25 N3 O6 | SMILES: | O=C(O)C(O)(C=4C=C3c2nc1ccc(O)c(c1cc2CN3C(=O)C=4CO)CN(C)C)CC | InChi: | InChI=1S/C23H25N3O6/c1-4-23(32,22(30)31)16-8-18-20-12(9-26(18)21(29)15(16)11-27)7-13-14(10-25(2)3)19(28)6-5-17(13)24-20/h5-8,27-28,32H,4,9-11H2,1-3H3,(H,30,31)/t23-/m0/s1 | 別名: | HYDROLYZED PRODUCT OF TOPOTECAN | 定義日: | 2002-01-15 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-2-{1-[(dimethylamino)methyl]-2-hydroxy-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl}-2-hydroxybutanoic acid |
|
 | TTI | 表記: | 2'-deoxy-5-telluroxouridine 5'-(dihydrogen phosphate) | 組成式: | C9 H13 N2 O8 P Te | SMILES: | [Te]=C2C(=O)NC(=O)N(C1OC(C(O)C1)COP(=O)(O)O)C2 | InChi: | InChI=1S/C9H13N2O8PTe/c12-4-1-7(19-5(4)3-18-20(15,16)17)11-2-6(21)8(13)10-9(11)14/h4-5,7,12H,1-3H2,(H,10,13,14)(H2,15,16,17)/t4-,5+,7+/m0/s1 | 別名: | 5-Tellurium-deoxyuridine-5'-phosphate | 定義日: | 2008-12-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2'-deoxy-5-telluroxouridine 5'-(dihydrogen phosphate) |
|
 | B31 | 表記: | (2S)-4-amino-N-[(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-(beta-D-xylofuranosyloxy)cyclohexyl]-2-hydroxybutanamide | 組成式: | C21 H41 N5 O12 | SMILES: | O=C(NC3C(O)C(OC1OC(C(O)C1O)CO)C(OC2OC(CN)C(O)C(O)C2N)C(N)C3)C(O)CCN | InChi: | InChI=1S/C21H41N5O12/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34)/t6-,7+,8-,9+,10+,11+,12-,13+,14-,15+,16+,17+,18+,20+,21-/m0/s1 | 別名: | Butirosin A | 定義日: | 2009-05-10 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-4-amino-N-[(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-(beta-D-xylofuranosyloxy)cyclohexyl]-2-hydroxybutanamide |
|
 | B32 | 表記: | 5'-S-[2-(decylamino)ethyl]-5'-thioadenosine | 組成式: | C22 H38 N6 O3 S | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)CSCCNCCCCCCCCCC)N | InChi: | InChI=1S/C22H38N6O3S/c1-2-3-4-5-6-7-8-9-10-24-11-12-32-13-16-18(29)19(30)22(31-16)28-15-27-17-20(23)25-14-26-21(17)28/h14-16,18-19,22,24,29-30H,2-13H2,1H3,(H2,23,25,26)/t16-,18-,19-,22-/m1/s1 | 別名: | S-adenosyl-N-decyl-aminoethyl (SADAE) | 定義日: | 2009-05-04 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5'-S-[2-(decylamino)ethyl]-5'-thioadenosine |
|
 | B40 | 表記: | (2S)-N-methyl-1-phenylpropan-2-amine | 組成式: | C10 H15 N | SMILES: | N(C(Cc1ccccc1)C)C | InChi: | InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1 | 別名: | Methamphetamine | 定義日: | 2009-03-19 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-N-methyl-1-phenylpropan-2-amine |
|
 | TUX | 表記: | 1,5-ANHYDRO-2-C-(CARBOXYMETHYL-N-HYDROXYAMIDE)-2-DEOXY-3-O-MYRISTOYL-D-GLUCITOL | 組成式: | C22 H41 N O7 | SMILES: | O=C(NO)CC1C(OC(=O)CCCCCCCCCCCCC)C(O)C(OC1)CO | InChi: | InChI=1S/C22H41NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-20(26)30-22-17(14-19(25)23-28)16-29-18(15-24)21(22)27/h17-18,21-22,24,27-28H,2-16H2,1H3,(H,23,25)/t17-,18+,21+,22+/m0/s1 | 別名: | TU-514 | 定義日: | 2003-03-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1,5-anhydro-2-deoxy-2-[2-(hydroxyamino)-2-oxoethyl]-3-O-tetradecanoyl-D-glucitol |
|
 | B4Q | 表記: | 2-(1~{H}-benzimidazol-2-yl)-~{N}-[[4-(2-ethylphenyl)-3-methyl-phenyl]methyl]ethanamine | 組成式: | C25 H27 N3 | SMILES: | CCc1ccccc1c2ccc(CNCCc3[nH]c4ccccc4n3)cc2C | InChi: | InChI=1S/C25H27N3/c1-3-20-8-4-5-9-22(20)21-13-12-19(16-18(21)2)17-26-15-14-25-27-23-10-6-7-11-24(23)28-25/h4-13,16,26H,3,14-15,17H2,1-2H3,(H,27,28) | 別名: | CAM4739 | 定義日: | 2017-09-09 | 最終更新日: | 2021-03-01 | 公開日: | 2018-02-28 | 識別子(ID): | 2-(1~{H}-benzimidazol-2-yl)-~{N}-[[4-(2-ethylphenyl)-3-methyl-phenyl]methyl]ethanamine |
|
 | B5L | 表記: | N~1~,N~1~,N~1~-tris(3-azaniumylpropyl)butane-1,4-diaminium | 組成式: | C13 H38 N5 | SMILES: | C([N+](CCC[NH3+])(CCC[NH3+])CCC[NH3+])CCC[NH3+] | InChi: | InChI=1S/C13H34N5/c14-6-1-2-10-18(11-3-7-15,12-4-8-16)13-5-9-17/h1-17H2/q+1/p+4 | 別名: | N4-bis(aminopropyl)spermidine | 定義日: | 2019-01-16 | 最終更新日: | 2021-03-01 | 公開日: | 2019-06-26 | 識別子(ID): | N~1~,N~1~,N~1~-tris(3-azaniumylpropyl)butane-1,4-diaminium |
|
 | TWO | 表記: | 3,4-dimethoxybenzoic acid | 組成式: | C9 H10 O4 | SMILES: | O=C(O)c1cc(OC)c(OC)cc1 | InChi: | InChI=1S/C9H10O4/c1-12-7-4-3-6(9(10)11)5-8(7)13-2/h3-5H,1-2H3,(H,10,11) | 別名: | VERATRIC ACID | 定義日: | 2012-04-09 | 最終更新日: | 2021-03-01 | 公開日: | 2013-02-15 | 識別子(ID): | 3,4-dimethoxybenzoic acid |
|